Cassaday & Co Wealth Management LLC Takes $312,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cassaday & Co Wealth Management LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 629 shares of the medical equipment provider's stock, valued at approximately $312,000.

A number of other hedge funds have also recently modified their holdings of ISRG. Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. Chilton Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the period. Global Financial Private Client LLC boosted its holdings in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the period. Finally, Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $26,000. Institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of research reports. Barclays lowered their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Robert W. Baird lowered their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Royal Bank Of Canada reduced their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. BTIG Research set a $566.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, July 14th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and an average price target of $592.86.

Intuitive Surgical Price Performance

Shares of ISRG opened at $518.62 on Friday. The firm has a market capitalization of $185.88 billion, a PE ratio of 76.04, a price-to-earnings-growth ratio of 5.50 and a beta of 1.64. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company's fifty day moving average price is $535.90 and its 200-day moving average price is $536.21.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period in the previous year, the company earned $1.50 earnings per share. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In related news, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction dated Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the transaction, the executive vice president directly owned 2,245 shares of the company's stock, valued at approximately $1,152,089.10. This trade represents a 43.09% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the transaction, the executive vice president directly owned 5,224 shares in the company, valued at $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 4,998 shares of company stock valued at $2,611,577. Insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.